Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Rosuvastatin and Ezetimibe in Healthy Males
NCT02127320Phase 1Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Jun 2014
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin and ezetimibe in hypercholesterolemia (6 arms), sponsored by Hanmi Pharmaceutical. Primary endpoints: Rosuvastatin Area Under the Curve at Steady State (AUCτ,ss) at Day 10, Rosuvastatin Maximum Plasma Concentration at Steady State (Cmax,ss) at Day 10 and 2 more. Started Jun 2014; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02127320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02127320.